Skip Navigation



QJM Advance Access published online on October 26, 2007

QJM, doi:10.1093/qjmed/hcm094
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
100/12/743    most recent
hcm094v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by van Beynum, I.M.
Right arrow Articles by Kapusta, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Beynum, I.M.
Right arrow Articles by Kapusta, L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

The MTHFR 677C->T polymorphism and the risk of congenital heart defects: a literature review and meta-analysis

I.M. van Beynum1, M. den Heijer2,3, H.J. Blom4 and L. Kapusta1

From the 1Children's Heart Centre, 2Department of Endocrinology, 3Department of Epidemiology and Biostatistics and 4Laboratory of Pediatrics and Neurology, Radboud University Medical Centre, Nijmegen, The Netherlands

Address correspondence to Dr I.M. van Beynum, Children's Heart Centre, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands. email: i.vanbeynum{at}cukz.umcn.nl


   Abstract

Background: Periconceptional folic acid supplementation may protect against congenital heart defects (CHDs). Identification of candidate genes in folate metabolism has suggested that the 677C->T polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene may be particularly associated with the risk of CHDs.

Aim: To assess the relationship between MTHFR 677C->T and CHDs by literature review and meta-analysis.

Methods: Studies were identified by searches of electronic literature for papers focussing on MTHFR 677C->T and the risk of any type of CHD. Both case-control comparisons and transmission-disequilibrium tests (TDTs) in family-based designs were included.

Results: We found 13 eligible studies. Of 10 case-control studies, four focused on the fetal polymorphism, two studied the maternal polymorphism, and a further four investigated both. Three further publications used a family-based association study to assess the effect of the T allele on cardiac development. Overall analysis yielded odds ratios of 1.3 (95%CI 0.97–1.73) and 1.2 (95%CI 0.83–1.74) for fetal and maternal MTHFR TT genotypes, respectively. TDTs revealed no association between fetal 677T allele and CHDs.

Discussion: This relatively small meta-analysis found no substantial evidence of increased CHD risk in individuals with MTHFR 677CT and TT genotypes. Heterogeneity regarding population background, study design and type of heart defects complicates the pooling and comparison of the studies. The effect of modification by periconceptional folic acid intake should be taken into account. Further larger studies and well-defined phenotypic subcategory analyses are needed to decide whether the MTHFR 677C->T polymorphism of the affected child and/or their mother is truly a risk factor for the development of CHDs.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Circ Cardiovasc GenetHome page
E. Goldmuntz, S. Woyciechowski, D. Renstrom, P. J. Lupo, and L. E. Mitchell
Variants of Folate Metabolism Genes and the Risk of Conotruncal Cardiac Defects
Circ Cardiovasc Genet, December 1, 2008; 1(2): 126 - 132.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.